These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34240037)

  • 1. Occult pulmonary arterial hypertension in patients with previous pulmonary tuberculosis.
    Kalla IS; Miri A; Seedat F
    Afr J Thorac Crit Care Med; 2020; 26(4):. PubMed ID: 34240037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Right ventricle performances with echocardiography and
    Liu J; Fei L; Huang GQ; Shang XK; Liu M; Pei ZJ; Zhang YX
    Exp Biol Med (Maywood); 2018 May; 243(9):754-761. PubMed ID: 29763366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hypertension in adults completing tuberculosis treatment.
    Allwood BW; Manie S; Stolbrink M; Hunter L; Matthee S; Meintjes G; Amosun SL; Pecoraro A; Walzl G; Irusen E
    Afr J Thorac Crit Care Med; 2023; 29(3):. PubMed ID: 37970573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.
    Argula RG; Karwa A; Lauer A; Gregg D; Silver RM; Feghali-Bostwick C; Schanpp LM; Egbert K; Usher BW; Ramakrishnan V; Hassoun PM; Strange C
    Ann Am Thorac Soc; 2017 May; 14(5):682-689. PubMed ID: 28282243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pulmonary arterial hypertension as leading manifestation of methylmalonic aciduria: clinical characteristics and gene testing in 15 cases].
    Liu XQ; Yan H; Qiu JX; Zhang CY; Qi JG; Zhang X; Xiao HJ; Yang YL; Chen YH; Du JB
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):768-777. PubMed ID: 29045954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of four-dimensional echocardiography combined with speckle tracking technique on the assessment of right heart function and prognosis in patients with pulmonary arterial hypertension].
    Zhang XM; Zhuang Q; Yang MH; Wang W; Zheng Y; Qiao ZQ; Shen JY; Shen XD
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Dec; 46(12):965-971. PubMed ID: 30572401
    [No Abstract]   [Full Text] [Related]  

  • 7. Selexipag for the treatment of children with pulmonary arterial hypertension: First multicenter experience in drug safety and efficacy.
    Hansmann G; Meinel K; Bukova M; Chouvarine P; Wåhlander H; Koestenberger M;
    J Heart Lung Transplant; 2020 Jul; 39(7):695-706. PubMed ID: 32362477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive diagnosis of pulmonary hypertension in chronic obstructive pulmonary disease. Comparison of ECG, radiological measurements, echocardiography and myocardial scintigraphy.
    Oswald-Mammosser M; Oswald T; Nyankiye E; Dickele MC; Grange D; Weitzenblum E
    Eur J Respir Dis; 1987 Nov; 71(5):419-29. PubMed ID: 3443164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for pulmonary arterial hypertension in patients with tuberculosis-destroyed lungs and their clinical characteristics compared with patients with chronic obstructive pulmonary disease.
    Jo YS; Park JH; Lee JK; Heo EY; Chung HS; Kim DK
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2433-2443. PubMed ID: 28860738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation of pulmonary hypertension].
    Natali D; Simonneau G; Humbert M; Montani D
    Rev Pneumol Clin; 2008 Jun; 64(3):151-61. PubMed ID: 18656791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right Ventricular and Right Atrial Function Are Less Compromised in Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction: A Comparison With Pulmonary Arterial Hypertension With Similar Pressure Overload.
    van Wezenbeek J; Kianzad A; van de Bovenkamp A; Wessels J; Mouratoglou SA; Braams NJ; Jansen SMA; Meulblok E; Meijboom LJ; Marcus JT; Vonk Noordegraaf A; José Goumans M; Jan Bogaard H; Handoko ML; de Man FS
    Circ Heart Fail; 2022 Feb; 15(2):e008726. PubMed ID: 34937392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary arterial hypertension.
    Montani D; Günther S; Dorfmüller P; Perros F; Girerd B; Garcia G; Jaïs X; Savale L; Artaud-Macari E; Price LC; Humbert M; Simonneau G; Sitbon O
    Orphanet J Rare Dis; 2013 Jul; 8():97. PubMed ID: 23829793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease.
    Rajaram S; Swift AJ; Capener D; Elliot CA; Condliffe R; Davies C; Hill C; Hurdman J; Kidling R; Akil M; Wild JM; Kiely DG
    J Rheumatol; 2012 Jun; 39(6):1265-74. PubMed ID: 22589263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of right ventricular free wall strain in pulmonary hypertension patients with pseudo-normalized tricuspid annular plane systolic excursion values.
    van Kessel M; Seaton D; Chan J; Yamada A; Kermeen F; Hamilton-Craig C; Butler T; Sabapathy S; Morris N
    Int J Cardiovasc Imaging; 2016 Jun; 32(6):905-12. PubMed ID: 26931558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tricuspid regurgitation progression and regression in pulmonary arterial hypertension: implications for right ventricular and tricuspid valve apparatus geometry and patients outcome.
    Medvedofsky D; Aronson D; Gomberg-Maitland M; Thomeas V; Rich S; Spencer K; Mor-Avi V; Addetia K; Lang RM; Shiran A
    Eur Heart J Cardiovasc Imaging; 2017 Jan; 18(1):86-94. PubMed ID: 26873457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk classification of pulmonary arterial hypertension by echocardiographic combined assessment of pulmonary vascular resistance and right ventricular function.
    Kawamukai M; Hashimoto A; Koyama M; Nagano N; Nishida J; Mochizuki A; Kouzu H; Muranaka A; Kokubu N; Nagahara D; Yuda S; Tsuchihashi K; Miura T
    Heart Vessels; 2019 Nov; 34(11):1789-1800. PubMed ID: 31119378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tricuspid regurgitation duration correlates with cardiovascular magnetic resonance-derived right ventricular ejection fraction and predict prognosis in patients with pulmonary arterial hypertension.
    Cho IJ; Oh J; Chang HJ; Park J; Kang KW; Kim YJ; Choi BW; Shin S; Shim CY; Hong GR; Ha JW; Chung N
    Eur Heart J Cardiovasc Imaging; 2014 Jan; 15(1):18-23. PubMed ID: 23704751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio for the Assessment of Right Ventricular-Arterial Coupling in Severe Pulmonary Hypertension.
    Tello K; Wan J; Dalmer A; Vanderpool R; Ghofrani HA; Naeije R; Roller F; Mohajerani E; Seeger W; Herberg U; Sommer N; Gall H; Richter MJ
    Circ Cardiovasc Imaging; 2019 Sep; 12(9):e009047. PubMed ID: 31500448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computed tomography-measured pulmonary artery to aorta ratio and EUTOS score for detecting dasatinib-induced pulmonary arterial hypertension.
    Toya T; Nagatomo Y; Kagami K; Yukino M; Yasuda R; Namba T; Ido Y; Kobayashi S; Masaki N; Yada H; Kimura F; Adachi T
    Int J Cardiovasc Imaging; 2019 Aug; 35(8):1435-1442. PubMed ID: 30715668
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.